Wang Li

机构：Tongji University, Central South University, Shanxi Medical University, Nankai University, Kunming Medical University, Zhengzhou University, Henan Cancer Hospital, ARTS Group (China), Second Xiangya Hospital of Central South University · ORCID：0000-0002-7618-7524

发表论文 92 篇 · 总被引 518 次 · h-index 13

代表论文

• Chemopreventive and therapeutic properties of anthocyanins in breast cancer: A comprehensive review (2022 · Nutrition Research · 被引 34)
• Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3 (2023 · Molecular Biology Reports · 被引 32)
• Integrated Bioinformatics Analysis for the Screening of Hub Genes andTherapeutic Drugs in Hepatocellular Carcinoma (2022 · Current Pharmaceutical Biotechnology · 被引 20)
• Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation (2023 · Journal of Hypertension · 被引 15)
• Chlorogenic acid regulates the proliferation and migration of high-grade serous ovarian cancer cells through modulating the miR199a5p/DDR1 axis (2022 · Acta Biochimica Polonica · 被引 14)
• Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials (2023 · Frontiers in Oncology · 被引 13)